Virtus Investment Advisers »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $46k 47k 0.98

More positions owned by Virtus Investment Advisers

Pimco Etf Tr Enhancd Short (EMNT)
Virtus Etf Tr Ii Duff & Phelps Cl (VCLN)
Vipshop Hldgs Sponsored Ads A (VIPS)
Icici Bank Adr (IBN)
Coca-Cola Bottling Co. Consolidated (COKE)
Apple (AAPL)
Microsoft Corporation (MSFT)
Warrior Met Coal (HCC)
Boise Cascade (BCC)
NVIDIA Corporation (NVDA)
Barrett Business Services (BBSI)
Rush Enterprises Cl A (RUSHA)
Gulfport Energy Corp Common Shares (GPOR)
Janus International Group In Common Stock (JBI)
Prestige Brands Holdings (PBH)

View all positions for Virtus Investment Advisers

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Steelhead Partners
Calamos Advisors
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1